Christopher Ngai
Corporate Officer/Principal presso CALLIDITAS THERAPEUTICS AB
Provenienza dei contatti di primo grado di Christopher Ngai
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 25 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Christopher Ngai tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Treasurer Director/Board Member | |
3I GROUP PLC | Investment Managers | Corporate Officer/Principal | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
SpineVision SA
SpineVision SA Medical SpecialtiesHealth Technology SpineVision SA develops and markets implants for the treatment of spinal disorders. It also designs instrumentation for the spinal treatments. Its products include Flex 2, Lumis, Plus/X-Plus, ULIS, Unithread, Spacevisions, and C3. The firm also offers solutions for spinal pathologies, such as lumbar degenerative disc diseases, deformities, cervical disorders, trauma, and tumors. The company was founded by Gérard Vanacker on July 16, 1999 and is headquartered in Antony, France. | Medical Specialties | Director/Board Member | |
PROBI AB | Biotechnology | Director/Board Member | |
Copenhagen Capacity
Copenhagen Capacity Financial ConglomeratesFinance Copenhagen Capacity provides investment promotion and economic development services. The private company is based in Copenhagen, Denmark. Asbjørn Overgaard Christiansen has been the CEO of the Danish company since 2020. | Financial Conglomerates | Director/Board Member | |
PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member | |
ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member | |
Georgia State University | College/University | Graduate Degree Masters Business Admin | |
MEDCAP AB | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
Stockholm School of Economics | College/University | Masters Business Admin Undergraduate Degree | |
University of Uppsala | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree | |
SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member Director/Board Member | |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Egalet Ltd.
Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
WEIFA ASA | Pharmaceuticals: Major | Director/Board Member | |
University of Lund | College/University | Graduate Degree Graduate Degree | |
University of Oslo | College/University | Graduate Degree Doctorate Degree | |
Sophion Bioscience A/S
Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark. | Medical Specialties | Director/Board Member | |
Memira AB
Memira AB Medical/Nursing ServicesHealth Services Memira AB owns and operates eye laser surgery clinics. It offers refractive surgery and lens replacement surgery. The firm also provides Memira RLE, which is a lens replacement surgery for the treatment of presbyopia and delivers treatment for astigmatism and hyperopia by laser. The company was founded by Per Jörgen Ringman and Bjart Eirik Dysthe in 2007 and is headquartered in Uppsala, Sweden. | Medical/Nursing Services | Director/Board Member | |
Genzyme Europe BV
Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Simparel, Inc.
Simparel, Inc. Miscellaneous Commercial ServicesCommercial Services Simparel, Inc. provides global supply chain management solutions. It provides apparel manufacturing software solutions. The firm offers enterprise resource planning, product lifecycle management, supply chain management, warehouse management system, mobile wholesale solution, electronic data interchange, manufacturing, material resource planning and financial management solutions. The company was founded in 2007 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chairman | |
Omega Fund Management UK LLP | Chief Operating Officer | ||
Baxter Medical AB | Corporate Officer/Principal | ||
BERGENBIO ASA | Pharmaceuticals: Major | Chairman | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Danish BioVenture General Partner ApS
Danish BioVenture General Partner ApS Financial ConglomeratesFinance Danish BioVenture General Partner ApS operates as a general partner and renders investment advice to K/S Danish BioVenture. It manages the administration and acts as a representative of Danish BioVenture in external commercial relations. The company was founded on June 26, 2009 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member | |
Egalet A/S
Egalet A/S Pharmaceuticals: MajorHealth Technology Egalet A/S operates as a specialty pharmaceuticals company. It develops opioid formulations for pain management based on abuse deterrent prolonged release erosion matrix technology in Denmark. The company develops prolonged and delayed release therapeutics for chronic pain management, including Parvulet, a delivery platform for facilitating dispensing of oral doses to pediatric and geriatric patient segments; and Egalet morphine. The company was founded by Jan Quistgaard in 1995 and is headquartered in Vaerloese, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
COMBIGENE AB | Pharmaceuticals: Major | Director/Board Member | |
Bomill Holding AB | Chairman | ||
Blueprint Genetics Oy
Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Biotechnology | Chairman | |
SEDANA MEDICAL AB | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
Swevet Holding AB
Swevet Holding AB Miscellaneous Commercial ServicesCommercial Services Swevet Holding AB is a supplier of medicines and consumables for animal care and veterinary operations. The private company is based in Sjobo, Sweden. The Swedish company has a wide range of products and offers fast delivery services. Swevet has extensive experience in the field, which enables it to provide safe advice on purchasing veterinary equipment and taking care of it. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Impilo AB
Impilo AB Investment ManagersFinance Impilo AB (Impilo) is an independent private equity firm founded in 2016 by Sören Mellstig. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Private Equity Investor | |
Tedsalus AB
Tedsalus AB Miscellaneous Commercial ServicesCommercial Services Tedsalus AB provides management and business development consulting services. The company is based in Stockholm, Sweden. The CEO of the Swedish company is Thomas Lennart Eklund. | Miscellaneous Commercial Services | Chief Executive Officer | |
Circassia AB
Circassia AB Medical SpecialtiesHealth Technology Circassia AB is a Swedish company that develops, manufactures, and sells equipment and preparations for medical diagnostics and related operations. The private company is based in Solna, Sweden. | Medical Specialties | Chairman | |
Excillum AB
Excillum AB Medical SpecialtiesHealth Technology Excillum AB manufactures radiographic X-ray, fluoroscopic X-ray, and therapeutic X-ray tubes. The private company is based in Kista, Sweden. The Swedish company was founded in 1999 by Hans Hertz, Oscar Hemberg. The CEO is David Lindblom. | Medical Specialties | Director/Board Member | |
Nefecon AB
Nefecon AB Pharmaceuticals: MajorHealth Technology Part of Calliditas Therapeutics AB, Nefecon AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company has developed a patented oral, delayed release formulation of budesonide called nefecon, which is designed to target mucosal B-cells present in the ileum where the disease originates, as per the predominant pathogenesis models. Nefecon is derived from the targit technology, which allows for the substance to pass through the stomach and intestine without being absorbed, and to be released in a pulse-like fashion only when it reaches the lower small intestine. The company has completed a large phase 2b trial, which showed that the combination of dose and optimized release profile is required to be effective in patients with IgA nephropathy. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member |
Statistiche
Distribuzione geografica
Svezia | 20 |
Stati Uniti | 8 |
Norvegia | 7 |
Regno Unito | 6 |
Danimarca | 5 |
Settori
Health Technology | 28 |
Consumer Services | 6 |
Finance | 5 |
Commercial Services | 5 |
Health Services | 2 |
Posizioni
Director/Board Member | 144 |
Corporate Officer/Principal | 57 |
Chairman | 49 |
Independent Dir/Board Member | 47 |
Director of Finance/CFO | 24 |
Contatti più connessi
Insiders | |
---|---|
Thomas Lennart Eklund | 57 |
Bengt Åke Julander | 36 |
Elmar Schnee | 31 |
Renée Aguiar-Lucander | 26 |
Fred Driscoll | 21 |
Hilde Furberg | 21 |
Henrik Stenqvist | 16 |
Diane Parks | 14 |
Margareta Elisabeth Björk | 12 |
Johan Erik Häggblad | 11 |
Åsa Hillsten | 11 |
Fredrik Johansson | 10 |
Molly Henderson | 10 |
Jonathan Schur | 8 |
Monika Tornsen | 6 |
- Borsa valori
- Insiders
- Christopher Ngai
- Connessioni Società